Last Updated on October 9, 2024 by The Health Master

Download NPPA notification No. S.O. 4660 (E) dt 25-10-2023, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 29 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 4660(E) dt 25-10-2023.

The notification states as follows:

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

A table is given below the article

Note:
(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have actually paid it or it is payable to the Government on the retail price mentioned in column (6) of the above-mentioned table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above, i.e., those who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to the fulfillment of all the applicable statutory requirements as laid down by the government under relevant statutes or rules,
including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of the manufacturer and marketing company specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer and marketing company
Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.

Table

Table

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydrami ne Hydrochloride Tablets	Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 5mg Caffeine (Anhydrous) IP 30mg Diphenhydramine Hydrochloride IP 25mg	1 Tablet	M/s Prosperity Drugs Pvt. Ltd. / M/s Torrent Pharmaceuticals Limited	3.85
2	Cilnidipine and Telmisartan Tablets	Each film coated tablet contains: Cilnidipine IP 20mg Telmisartan IP 40mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd.	14.15
3	Ibuprofen Solution for Infusion 400mg/100ml	Each 100ml contains: Ibuprofen IP 400mg Water for injection IP q. s.	1 ML	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Neon Laboratories Limited	2.63
4	Phenylephrine Hydrochloride and Chlorphenirami ne Maleate Drops IP	Each ml contains: Phenylephrine Hydrochloride IP 5mg Chlorpheniramine Maleate IP 2mg	1 ML	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Apex Laboratories Pvt. Ltd.	4.28
5	Ofloxacin and Dexamethasone Eye / Ear Drops	Each ml contains: Ofloxacin IP 0.3% w/v Dexamethasone Sodium Phosphate IP eq. to Dexamethasone Phosphate 0.1% w/v Benzalkonium Chloride Solution IP 0.02% (As preservative)	1 ML	M/s Axa Parenterals Ltd. / M/s Intas Pharmaceuticals Ltd.	6.00
6	Montelukast and Fexofenadine Hydrochloride suspension	Each 5ml contains: Montelukast Sodium IP eq. to Montelukast 4mg Fexofenadine Hydrochloride IP 60mg	1 ML	M/s Synokem Pharmaceuticals Ltd. / M/s Cipla Ltd.	1.79
7	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film coated bilayer tablet contains: Linagliptin 2.5mg Metformin Hydrochloride (as Extended release) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s ERIS Lifesciences Limited	9.60
8	Calcium, Magnesium, Vitamin D3 & Zinc Tablets	Each uncoated tablet contains: Calcium Citrate USP 1000mg Vitamin D3 IP 200IU Magnesium Hydroxide IP eq. to elemental magnesium 100mg Zinc Sulphate Monohydrate IP eq. to elemental Zinc 4mg	1 Tablet	M/s Hanuchem Laboratories / M/s Mankind Pharma Ltd.	9.64
9	Mefenamic Acid + Paracetamol Suspension	Each 5ml contains: Mefenamic Acid IP 50mg Paracetamol IP 125mg	1 ML	M/s Innova Captab Limited / M/s Macleods Pharmaceuticals Limited	0.68
10	Mefenamic Acid+ Paracetamol Suspension	Each 5ml contains: Mefenamic Acid IP 100mg Paracetamol IP 250mg	1 ML	M/s Innova Captab Limited / M/s Macleods Pharmaceuticals Limited	0.82

11	Calcium, Vitamin D3 & Vitamin B12 Tablets	Each film coated tablet contains: Calcium Carbonate 1250mg from an organic source (Oyster shell) eq. to Elemental Calcium 500mg Vitamin D3 IP 500 IU Vitamin B12 IP 15mcg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Cipla Ltd.	8.58
12	Atorvastatin, Clopidogrel and Aspirin Capsules	Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As two film coated tablet) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg, Aspirin IP 75mg (As Gastro- resistant tablet)	1 Capsule	M/s Safetab Life Science / M/s Lupin Limited	13.22
13	Ferrous Ascorbate, Folic Acid, Zinc & Cyanocobalamin Tablets	Each film coated tablet contains: Ferrous Ascorbate IP eq. to Elemental Iron 100mg Folic Acid IP 1.5mg Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 22.5mg Cyanocobalamin IP 15mcg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Cipla Ltd.	10.37
14	Methylcobalami n, Nicotinamide, Pyridoxine Hydrochloride & D-panthenol Injection	Each 2ml contains: Methylcobalamin IP 1000mcg, Nicotinamide 100mg, Pyridoxine Hydrochloride IP 100mg, D-panthenol IP 50mg Benzyl Alcohol IP 2% v/v (As preservative)	Per vial of 2ml	M/s Fast Pharma Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	66.50
15	Atorvastatin & Ezetimibe Tablets	Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg Ezetimibe IP 10mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Emcure Pharmaceuticals Limited	32.61
16	Glycopyrronium + Formoterol Fumarate + Budesonide powder for Inhalation	Each capsule contains: Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 12mcg Glycopyrrolate IP eq. to Glycopyrronium 25mcg Budesonide IP 400mcg	1 Capsule	M/s Penta Kraft / M/s Mankind Pharma Ltd.	12.98
17	Omeprazole & Domperidone Capsules IP	Each hard gelatin capsule contains: Omeprazole IP 20mg (As enteric coated pellets) Domperidone IP 10mg (As coated pellets)	1 Capsule	M/s Prochem Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	6.14
18	Nimesulide& Paracetamol tablet	Each uncoated tablet contains: Nimesulide BP 100mg Paracetamol IP 325mg	1 Tablet	M/s Lucent Biotech Limited / M/s Torrent Pharmaceuticals Ltd.	3.91
19	Sitagliptin Phosphate & Metformin Hydrochloride Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25mg eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Windlas Biotech Limited	9.16
20	Sitagliptin Phosphate & Metformin Hydrochloride Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25mg eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Windlas Biotech Limited	10.37

21	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Zuventus Healthcare Limited	17.16
22	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Zuventus Healthcare Limited	16.09
23	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Primus Remedies Pvt. Ltd.	17.16
24	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Primus Remedies Pvt. Ltd.	16.09
25	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film bilayer coated tablet contains: Linagliptin 5mg Metformin Hydrochloride (as Extended release) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s ERIS Lifesciences Limited	14.37
26	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film coated Bilayered tablet contains: Linagliptin 5mg Metformin IP 1000mg Hydrochloride (as Extended release}	1 Tablet	M/s Alkem Health Science (A unit of Alkem Laboratories Ltd.) / M/s Alkem Laboratories Ltd.	14.37
27	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film coated Bilayered tablet contains: Linagliptin 5mg Metformin Hydrochloride IP 500mg (as Extended release)	1 Tablet	M/s Alkem Health Science (A unit of Alkem Laboratories Ltd.) / M/s Alkem Laboratories Ltd.	12.92
28	Dapagliflozin, Sitagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited	14.62
29	Dapagliflozin, Sitagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited	13.55

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos by The Health Master, click on the below YouTube icon:

• Key Notes on Revised Schedule M: Point No. 14 – Materials
  December 25, 2024
• USFDA issues VAI status to Biocon for Bengaluru API facility
  December 25, 2024
• Bulk drug import from China continues to rise in 5 years
  December 25, 2024
• High Court stays action against Pharma Units manufacturing Nutraceuticals
  December 25, 2024
• NPPA fixed retail price of 7 formulations: December 2024
  December 24, 2024
• Revised Schedule M: Industry seeks balance between Quality and Viability
  December 24, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: